|
| Peripheral area | Central area |
|
| CD34 | | |
| Clone QBEnd-10, Leica, 1 : 100 dilution | ± | +++ (Sinusoidal capillarization pattern) |
| GS | | |
| Clone 6, BD Transduction Laboratories™, 1 : 600 dilution | + (Heterogeneous) | ++ (Diffuse) |
| SAA | | |
| Clone mc1, Dako, 1 : 100 dilution | Inconclusive | Inconclusive |
| CRP | | |
| Clone y284, Abcam, 1 : 500 | +++ | +++ |
| LFABP | | |
| Clone EPR20464, Abcam, 1 : 1,000 | Preserved in neoplastic cells | Preserved in neoplastic cells |
| Glypican-3 | | |
| Clone GC33, Ventana Medical Systems, pre-diluted | − | − |
| HSP-70 | | |
| Clone W27, NeoMarkers, 1 : 100 | − | − |
| Beta-catenin | | |
| Clone 14, Cell Marque, pre-diluted | + (Membranar) | + (Membranar) |
| CK7 | | |
| Clone SP52, Ventana Medical Systems, pre-diluted | + (Biliary ducts) | − (Absence of biliary ducts) |
| CK19 | | |
| Clone A53-B/A2.26, Cell Marque, pre-diluted | | |
|
